Celtarys Research

www.celtarys.com

Celtarys Research develops and commercializes new chemical tools to spread the use of fluorescence-based methods in drug discovery. Our chemical conjugation technology allows us to develop in a competitive manner and short time (<3 months) customized fluorescent ligands with optimal pharmacological and photophysical properties for any druggable target. We have initially applied our technology to develop versatile fluorescent GPCR ligands which we have externally validated in several HTS assays such as FRET, Fluorescence Polarization, High Content Screening or Flow Cytometry, avoiding the use of radioactivity. Products: We have a catalogue of 20 fluorescent ligands for different families of GPCRs, including adenosine, dopamine, serotonin, cannabinoid and muscarinic receptors. Compared to other available fluorescence-based technologies, our ligands are: -More flexible and efficient -With high affinity and selectivity for the target -With a wide variety of fluorochromes -Compatible with various assays: FRET, polarized fluorescence, High Content Screening, flow cytometry... -Rational design portfolio covering entire GPCR families - With low cost and scalable production Services: We also offer custom synthesis of specific fluorescent ligands for any target with therapeutic potential. Our technology allows us to develop in a competitive way and in a short time (<3 months) customized fluorescent ligands with optimal pharmacological and photophysical properties.

Read more

Reach decision makers at Celtarys Research

Lusha Magic

Free credit every month!

Celtarys Research develops and commercializes new chemical tools to spread the use of fluorescence-based methods in drug discovery. Our chemical conjugation technology allows us to develop in a competitive manner and short time (<3 months) customized fluorescent ligands with optimal pharmacological and photophysical properties for any druggable target. We have initially applied our technology to develop versatile fluorescent GPCR ligands which we have externally validated in several HTS assays such as FRET, Fluorescence Polarization, High Content Screening or Flow Cytometry, avoiding the use of radioactivity. Products: We have a catalogue of 20 fluorescent ligands for different families of GPCRs, including adenosine, dopamine, serotonin, cannabinoid and muscarinic receptors. Compared to other available fluorescence-based technologies, our ligands are: -More flexible and efficient -With high affinity and selectivity for the target -With a wide variety of fluorochromes -Compatible with various assays: FRET, polarized fluorescence, High Content Screening, flow cytometry... -Rational design portfolio covering entire GPCR families - With low cost and scalable production Services: We also offer custom synthesis of specific fluorescent ligands for any target with therapeutic potential. Our technology allows us to develop in a competitive way and in a short time (<3 months) customized fluorescent ligands with optimal pharmacological and photophysical properties.

Read more
icon

Country

icon

City (Headquarters)

Santiago de Compostela

icon

Employees

1-10

icon

Founded

2021

icon

Social

  • icon
  • icon

Employees statistics

View all employees

Potential Decision Makers

  • Co - Founder and Chairman of the Board of Directors

    Email ****** @****.com
    Phone (***) ****-****
  • Co - Founder and Chief Scientific Officer

    Email ****** @****.com
    Phone (***) ****-****
  • Member of the Board of Directors

    Email ****** @****.com
    Phone (***) ****-****
  • Experimental Medicinal Chemist

    Email ****** @****.com
    Phone (***) ****-****

Reach decision makers at Celtarys Research

Free credits every month!

My account

Sign up now to uncover all the contact details